HCSGD entry for ENG
1. General information
Official gene symbol | ENG |
---|---|
Entrez ID | 2022 |
Gene full name | endoglin |
Other gene symbols | END HHT1 ORW1 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | IDA | biological_process |
GO:0001300 | Chronological cell aging | IEA IEP | biological_process |
GO:0001569 | Patterning of blood vessels | IEA ISS | biological_process |
GO:0001570 | Vasculogenesis | IEA IMP | biological_process |
GO:0001666 | Response to hypoxia | IDA | biological_process |
GO:0001934 | Positive regulation of protein phosphorylation | IDA IEA | biological_process |
GO:0001937 | Negative regulation of endothelial cell proliferation | IMP | biological_process |
GO:0001947 | Heart looping | IEA ISS | biological_process |
GO:0003084 | Positive regulation of systemic arterial blood pressure | IMP | biological_process |
GO:0003273 | Cell migration involved in endocardial cushion formation | IEA | biological_process |
GO:0004888 | Transmembrane signaling receptor activity | NAS | molecular_function |
GO:0005024 | Transforming growth factor beta-activated receptor activity | IDA | molecular_function |
GO:0005072 | Transforming growth factor beta receptor, cytoplasmic mediator activity | IDA | molecular_function |
GO:0005114 | Type II transforming growth factor beta receptor binding | IEA IPI ISS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005534 | Galactose binding | IDA | molecular_function |
GO:0005539 | Glycosaminoglycan binding | IDA ISS | molecular_function |
GO:0005615 | Extracellular space | IDA | cellular_component |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005730 | Nucleolus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0006355 | Regulation of transcription, DNA-templated | IMP | biological_process |
GO:0006468 | Protein phosphorylation | IDA | biological_process |
GO:0007155 | Cell adhesion | IEA | biological_process |
GO:0007179 | Transforming growth factor beta receptor signaling pathway | IDA | biological_process |
GO:0008152 | Metabolic process | IDA | biological_process |
GO:0009897 | External side of plasma membrane | IDA | cellular_component |
GO:0009986 | Cell surface | IDA IEA | cellular_component |
GO:0010628 | Positive regulation of gene expression | IEA | biological_process |
GO:0010862 | Positive regulation of pathway-restricted SMAD protein phosphorylation | IDA IMP | biological_process |
GO:0016310 | Phosphorylation | IDA | biological_process |
GO:0016477 | Cell migration | IMP | biological_process |
GO:0017015 | Regulation of transforming growth factor beta receptor signaling pathway | IDA IEA | biological_process |
GO:0022009 | Central nervous system vasculogenesis | IMP | biological_process |
GO:0022617 | Extracellular matrix disassembly | IMP | biological_process |
GO:0030155 | Regulation of cell adhesion | TAS | biological_process |
GO:0030336 | Negative regulation of cell migration | IDA | biological_process |
GO:0030509 | BMP signaling pathway | TAS | biological_process |
GO:0030512 | Negative regulation of transforming growth factor beta receptor signaling pathway | TAS | biological_process |
GO:0030513 | Positive regulation of BMP signaling pathway | IDA | biological_process |
GO:0031953 | Negative regulation of protein autophosphorylation | IDA | biological_process |
GO:0031960 | Response to corticosteroid | IEA | biological_process |
GO:0032967 | Positive regulation of collagen biosynthetic process | IEA | biological_process |
GO:0034713 | Type I transforming growth factor beta receptor binding | IPI ISS | molecular_function |
GO:0035556 | Intracellular signal transduction | IDA | biological_process |
GO:0036273 | Response to statin | IEA | biological_process |
GO:0042060 | Wound healing | IMP | biological_process |
GO:0042127 | Regulation of cell proliferation | TAS | biological_process |
GO:0042325 | Regulation of phosphorylation | TAS | biological_process |
GO:0042803 | Protein homodimerization activity | IEA IPI | molecular_function |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | IDA | biological_process |
GO:0048185 | Activin binding | TAS | molecular_function |
GO:0048745 | Smooth muscle tissue development | IEA ISS | biological_process |
GO:0048844 | Artery morphogenesis | IEA ISS | biological_process |
GO:0048845 | Venous blood vessel morphogenesis | IEA ISS | biological_process |
GO:0048870 | Cell motility | IMP | biological_process |
GO:0050431 | Transforming growth factor beta binding | IEA IPI | molecular_function |
GO:0051001 | Negative regulation of nitric-oxide synthase activity | IMP | biological_process |
GO:0060326 | Cell chemotaxis | IMP | biological_process |
GO:0060348 | Bone development | IEA | biological_process |
GO:0060394 | Negative regulation of pathway-restricted SMAD protein phosphorylation | IMP | biological_process |
GO:0070022 | Transforming growth factor beta receptor homodimeric complex | IC | cellular_component |
GO:0070278 | Extracellular matrix constituent secretion | IEA | biological_process |
GO:0070483 | Detection of hypoxia | IDA | biological_process |
GO:0071260 | Cellular response to mechanical stimulus | IEA | biological_process |
GO:0071559 | Response to transforming growth factor beta | IEA | biological_process |
GO:0072563 | Endothelial microparticle | IEA | cellular_component |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0071567950 | 0.9800650241 | 0.2208092506 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0319092520 |
GSE13712_SHEAR | Up | 0.4194046883 |
GSE13712_STATIC | Up | 0.1494261639 |
GSE19018 | Up | 0.1853517898 |
GSE19899_A1 | Down | -0.0313220810 |
GSE19899_A2 | Up | 0.5784070482 |
PubMed_21979375_A1 | Up | 0.1586422453 |
PubMed_21979375_A2 | Up | 0.8435747699 |
GSE35957 | Down | -0.1280321703 |
GSE36640 | Up | 1.0487598082 |
GSE54402 | Up | 0.1512866747 |
GSE9593 | Up | 0.2929359136 |
GSE43922 | Up | 0.2432623157 |
GSE24585 | Up | 0.1061177160 |
GSE37065 | Down | -0.0773934408 |
GSE28863_A1 | Up | 0.8898576674 |
GSE28863_A2 | Up | 0.4263443569 |
GSE28863_A3 | Up | 0.5442421459 |
GSE28863_A4 | Up | 0.0202503171 |
GSE48662 | Up | 0.7834408350 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-let-7b-5p | MIMAT0000063 | MIRT032385 | Proteomics | Functional MTI (Weak) | 18668040 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 13 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27067789 | In this study of 126 patients, we investigated the association between Endoglin expression in GC peritoneum and the clinicopathological features |
27067789 | The prognosis of patients was evaluated according to Endoglin and ID1 expression |
27067789 | Endoglin and ID1 expression was evaluated by Western blot |
27067789 | Our results showed that positive staining of Endoglin (38%) was associated with a higher TNM stage and higher incidence of GCPD (both P < |
27067789 | Kaplan-Meier analysis showed that the patients who were Endoglin positive had a shorter survival time compared with Endoglin-negative patients (P = |
27067789 | Using the HPMC and GCC adherence and invasion assay, we demonstrated that transforming growth factor beta 1 (TGF-beta)1-induced HPMC senescence was attenuated by silencing the Endoglin expression, which also prevented GCC attachment and invasion |
27067789 | Our study indicated a positive correlation between Endoglin overexpression and GCPD |
27067789 | Up-regulated Endoglin expression induced HPMC senescence via TGF-beta1 pathway |
26196672 | CD105 levels varied (BMA13 87 |
25437179 | When compared with N-UC-MSCs, GDM-UC-MSCs showed decreased cell growth and earlier cellular senescence with accumulation of p16 and p53, even though they expressed similar levels of CD105, CD90, and CD73 MSC marker proteins |
24777481 | Expression of endoglin isoforms in the myeloid lineage and their role during aging and macrophage polarization |
24777481 | Endoglin plays a crucial role in pathophysiological processes such as hereditary hemorrhagic telangiectasia (HHT), preeclampsia and cancer |
24777481 | Endoglin expression is upregulated during the monocyte-to-macrophage transition, but little is known about its regulation and function in these immune cells |
24777481 | Two different alternatively spliced isoforms of endoglin have been reported, L-endoglin and S-endoglin |
24777481 | Gene expression and functional studies suggested that there was a non-redundant role for each endoglin isoform in monocyte biology |
24170370 | 5 cc of bone marrow was needed to predictably isolate aBMSCs, and, regardless of methodology for harvest, cell-surface marker expression of CD73, CD90, CD105, and Stro-1 was similar for aBMSCs, being 89 |
22470345 | Based on its senescence-dependent involvement in alternative splicing, we postulate that SRSF1 is a key marker of EC senescence, regulating the expression of alternative isoforms of target genes such as endoglin (ENG), vascular endothelial growth factor A (VEGFA), tissue factor (T3), or lamin A (LMNA) that integrate in a common molecular senescence program |
22242193 | Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways |
20225285 | The expressions of CD166, CD49a, and CD106 decreased, whereas those of CD10, CD29, CD44, CD73, CD90, and CD105 showed no significant change |
20132052 | FACS analysis confirmed expression of the stem cell markers CD44, CD90, CD105, and CD166, but negative expression of CD34 and CD45 ruling out a hematopoietic or fibrocyte origin for these progenitors |
18974388 | Here, we have analyzed the expression, during EC senescence, of 2 different isoforms (L, long; S, short) of endoglin, an auxiliary transforming growth factor (TGF)-beta receptor involved in vascular remodeling and angiogenesis |
18974388 | As evidenced by RT-PCR, the S/L ratio of endoglin isoforms was increased during senescence of human ECs in vitro, as well as during aging of mice in vascularized tissues |
17371154 | Flow cytometric analysis indicated a strong need to investigate for novel cell-surface characteristic markers of BMSCs because there was no obvious difference in the expression of the selected characteristic BMSC cell surface markers CD29, CD44, CD90, CD105, and CD166 between fast-growing and slow-growing clones |
16507351 | Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells |
16507351 | AIM: To compare the differentiation capacity of human CD105(+) MSCs obtained from young and elderly donors |
16507351 | Adipogenic and osteogenic potential of CD105(+) MSCs was demonstrated |
16507351 | CONCLUSION: Age does not influence the adipogenic and myogenic differentiation potential of human CD105(+) MSCs |
16229018 | There was a high expression of CD90, CD29, CD44 and CD105 and variable and moderate expression of CD166 and CD106 at the start of MSC culture and at each passage during expansion |
Entries Per Page
Displaying Page of